Juva Life Inc.

OTC: JUVAF · Healthcare · Drug Manufacturers - Specialty & Generic

Canadian filerHQ Vancouver, BCCIK 0001778651Reports USD

#1 of 1,422 Healthcare companies by revenue

EA Score

——

FH —DQ —GM —SS 15

v0.1 · 5/100 weight · pillars only

↑ Piotroski F, Altman-Z · ↓ market scale, listing tenure

Methodology →

Revenue TTM

$8.0M

Rev growth YoY (TTM)

+43.5%

Net income (FY)

—

Employees

—

as of 2026-07-12

Market cap

$1.6k

as of 2026-07-12

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

No filed financials — private or non-XBRL filer.

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

What is Juva Life Inc.’s financial profile?

Juva Life Inc. has no structured financials on file — private or non-XBRL filer.

Peers · Healthcare

iBX Group, Inc.——Evelo Biosciences, Inc.——Redwood Scientific Technologies, Inc.——Assure Holdings Corp.——9 Meters Biopharma, Inc.——MSP Recovery, Inc.——

Key facts

CEOMathew Lee

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

HeadquartersVancouver, BC

ExchangeOTC: JUVAF

Employees—

IPO date2021-01-08

Latest filings

No filings loaded.

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.